Mary Tanner - Evotec AG Insider

Evotec AG -- USA Stock  

USD 20.35  0.00  0.00%

Member of the Supervisory Board

Ms. Mary C. Tanner was Member of the Supervisory Board of Evotec AG since January 19 2005. She has devoted 22 years to the health care and consumer products industry as Senior Managing Director at Bear Stearns and Lehman Brothers both global investment banks. In 2004 Ms. Tanner founded Life Sciences Partners which specializes in healthcare investment and advisory work following her retirement from Bear Stearns in the same year. During her 22 years at Bear Stearns and Lehman Ms. Tanner led or supervised over 575 transactions including 220 mergers acquisitions and divestitures. Ms. Tanner also developed a specialization in the biotechnology industry as it emerged over the last 20 years. She was NonExecutive Member of the Board of Directors at Synvista Therapeutics Inc. Montvale. Ms. Tanner received her university degree from Harvard in 1973 in philosophy and related fields.
  Executive Since 2005      
49 40 5 60 81 0

Management Efficiency

The company has return on total asset (ROA) of 4.56 % which means that it generated profit of $4.56 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 11.13 % meaning that it generated $11.13 on every $100 dollars invested by stockholders.
The company has accumulated 213.13 M in total debt with debt to equity ratio (D/E) of 53.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Evotec AG has Current Ratio of 0.68 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Entity Summary

Evotec AG provides drug discovery solutions to the pharmaceutical and biotechnology companies, academic institutions, and foundations and not-for-profit organizations worldwide. Evotec AG was founded in 1993 and is headquartered in Hamburg, Germany. Evotec AG is traded on OTC Market in USA.Evotec AG (EVOTF) is traded on OTC Market in USA. It is located in Manfred Eigen Campus and employs 1,238 people.

Fix Portfolio

Optimize Your Risk-Return Tradeoff
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Evotec AG to your portfolio

Top Management

Evotec AG Leadership Team
Werner Lanthaler, CEO
Claus Braestrup, Executive
Michael Shalmi, Executive, MBA
Mario Polywka, COO, Ph.D
Mary Tanner, Executive
Roland Oetker, Chairman
Andreas Pinkwart, Executive
Paul Herrling, Executive, Ph.D
Colin Bond, CFO, MBA
Cord Dohrmann, Executive
Iris LoewFriedrich, Executive, Ph.D
Bernd Hirsch, Executive
Enno Spillner, CFO
Elaine Sullivan, Executive
Wolfgang Plischke, Chairman, Ph.D

Stock Performance

Evotec AG Performance Indicators